7 Signs It Is Time to Change Your Medical Billing Company

EditorialOriginal analysis · MedOutbound Editorial
TL;DR

Seven objective signals warrant considering a billing-vendor switch: days-in-AR above 55 for two consecutive quarters, denial rate above 12% trending up, first-pass acceptance below 90% and not improving, net collection ratio below 93%, missed reports or missed responses to escalations, staff turnover on your account exceeding 40% annually, and refusal to provide MGMA-benchmarked performance data on request. Two or more signals sustained over two quarters usually justify a formal vendor review. A single signal for a single month is normal noise.

Billing vendors do not fail overnight. They fail in slow, measurable, ignorable increments. By the time a practice recognizes the switch is overdue, they have usually left 6-18 months of collections on the table.

These seven signals are the objective ones. Any two, sustained over two quarters, warrant a formal review.

The 7 signals

1. Days-in-AR above 55 for two consecutive quarters

MGMA benchmarks the median at 47 days. Better performers hit 36. Days-in-AR climbing into the mid-50s and staying there means either front-end (charge lag), mid-cycle (first-pass acceptance), or back-end (follow-up capacity) is broken. All three are the vendor's job to identify and fix.

Red line: 55 days for two consecutive quarters, or any single quarter above 65.

2. Denial rate above 12% and trending up

HFMA top-quartile is under 5%. Industry average is 9-12%. A denial rate above 12% that is not stable — but rising quarter over quarter — signals structural gaps: payer-rule updates the vendor is not tracking, coder training decay, or a shift in payer mix the vendor has not adapted to.

Red line: two consecutive quarters above 12% with a positive trend line.

3. First-pass acceptance rate below 90% and not improving

HFMA target is 95-98%. Industry floor is 90%. First-pass below 90% is expensive — every rejection costs $25-$118 to rework — and it foreshadows worsening days-in-AR.

Red line: two consecutive quarters below 90%, with no documented improvement plan from the vendor.

4. Net collection ratio below 93%

Net collection ratio is the least manipulable metric. Below 93% means money is being lost through timely-filing lapses, missed appeals, or aggressive write-offs the vendor is not documenting.

Red line: two consecutive months below 93%, or any single month below 90%.

5. Missed reports or missed responses to escalations

Operational sloppiness on communication is a leading indicator of operational sloppiness on billing. If the monthly A/R report arrives late two months in a row, or if a written escalation goes unanswered for a business week, expect the KPIs to follow.

Red line: two missed reporting deadlines in a rolling 90-day window, or any single escalation ignored beyond a business week.

6. Staff turnover on your account exceeding 40% annually

Medical biller turnover industry-wide runs 15-25% annually. Turnover above 40% on your specific account means either the vendor is understaffing you (rotating juniors through) or your account is unusually painful to work.

Red line: 40%+ annual turnover on your account for two consecutive years.

7. Refusal to provide MGMA-benchmarked performance data on request

A credible vendor knows their numbers against MGMA and HFMA benchmarks and will share them within a business week of request. A vendor that stalls, redirects, or claims 'benchmarks do not apply to your specialty' is telling you the numbers are not defensible.

Red line: any refusal or stall over two business weeks.

Signal severity table

SignalWarning thresholdRed-line threshold
Days in A/R50+55+ for 2 quarters
Denial rate10-12%12%+ trending up
First-pass acceptance90-92%Under 90% for 2 quarters
Net collection ratio93-95%Under 93%
Missed reports / responses1 in rolling quarter2 in rolling quarter
Account staff turnover30-40%40%+
Data transparencyDelayed responseRefusal or stall

What to do when signals fire

Step 1: Confirm the diagnosis (2-4 weeks)

Ask the vendor for a root-cause analysis. Categorize the underperformance: practice-side (documentation, eligibility capture, scheduling), vendor-side (coding, follow-up, appeal capacity), or payer-side (contract terms, prior-auth burden, payment lag). Not all underperformance warrants a switch.

Step 2: Formal improvement plan (60-90 days)

If the root cause is vendor-side, request a written 60-90 day improvement plan with specific KPI targets. Track weekly. About 30% of underperforming vendors recover with a documented plan; the other 70% do not.

Step 3: Begin evaluating alternatives (in parallel)

Run the vendor RFP process quietly while the improvement plan runs. Have a shortlist of 2-3 alternative vendors evaluated by the end of the improvement window.

Step 4: Decision at end of improvement window

If KPIs recovered to acceptable ranges: continue with current vendor with tighter monitoring. If KPIs did not recover: initiate transition per the 90-day switch plan.

Bottom line

Do not switch on a hunch. Switch on a documented, sustained pattern where the vendor has been given a chance to fix the pattern. That standard protects you against reflexive switches (which are expensive) and against tolerating chronic underperformance (which is more expensive).

Continue the conversation

Working on this problem?

If this hit close to home, tell us where you're stuck. One reply from a real inbox — no drip campaigns.

Editorial · geo-cluster-c-choose · widget-tag: signs-to-change-medical-billing-company

Answers

How do I know if a bad month is a real problem or just noise?
Look for the 2x2 rule: two or more of the seven signals appearing in two consecutive quarters. Single-month drops are usually noise from staff PTO, EHR outages, or payer processing delays. Sustained multi-signal degradation over two quarters is a structural problem and warrants formal review.
Should I confront the current vendor before starting a switch process?
Yes. A written 60-day improvement plan with specific KPI targets is the right first step. About 30% of underperforming vendors respond to a formal action plan and recover. The other 70% do not, and you have documented the case for termination while the plan runs. Never announce a search until the improvement window has elapsed.
What if the underperformance is our fault, not the vendor's?
Common and worth diagnosing before switching. Ask the vendor to categorize the last quarter's rejections and denials by root cause: eligibility errors (front-end, usually practice-side), coding errors (mid-cycle, usually vendor-side), payer-specific rule gaps (mixed responsibility), or provider documentation gaps (physician-side). If more than 60% is practice-side, switching vendors will not solve the problem.